GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif.,…
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
February 13, 2026 16:30 ET | Source: Natural Alternatives International Inc CARLSBAD,…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million…
Ocean Tomo Releases 2025 Intangible Asset Market Value Study Results
50-year study of the US market and 20 years of foreign market…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million…
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided…
